期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

加强垂体腺瘤的基础与临床研究 被引量：13

Strengthening basic and clinical researches on pituitary adenoma
下载PDF
导出
作者 章翔 甄海宁
机构地区 第四军医大学西京医院神经外科
出处 《中华神经外科疾病研究杂志》 CAS 2005年第5期385-387,共3页 Chinese Journal of Neurosurgical Disease Research
基金 国家自然科学基金资助项目(30370512)
关键词 垂体腺瘤 基础研究 临床研究
分类号 R379.41 [医药卫生—病原生物学]
  • 相关文献

参考文献20

  • 1Alexander JM, Biller BM, Bikkal H, et al. Clinically nonfunctioning pituitary tumors are monoclonal in origin [ J]. J Clin Invest, 1990, 86( 1 ): 336 - 340.
  • 2Schulte HM, Oldfield EH, Allolio B, et al. Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis [ J]. J Clin Endocrinol Metab,1991, 73(6): 1302 - 1308.
  • 3Finelli P, Giardino D, Rizzi N, et al. Non-random trisomies of chromosomes 5, 8 and 12 in the prolactinoma sub-type of pituitary adenomas: conventional cytogenetics and interphase FISH study [ J ].Int J Cancer, 2000, 86(3): 344 -350.
  • 4Bello M J, de Campos JM, Kusak ME, et al. Chromosomal abnormalities in pituitary adenomas [ J ]. Cancer Genet Cytogenet,2001, 124(1): 76 -79.
  • 5Ma W, Ikeda H, Yoshimoto T. Glinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas [J]. Cancer, 2002,95(2): 258 -266.
  • 6Sanno N, Teramoto A, Osamura RY, et al. Pathology of pituitary tumors [J]. Neurosurg Clin N Am, 2003, 14(1): 25 -39.
  • 7Osamura RY, Egashira N, Miyai S, et al. Molecular pathology of the pituitary. Development and functional differentiation of pituitary adenomas [J]. Front Horm Res, 2004, 32(1): 20-33.
  • 8Seemann N, Kuhn D, Wrocklage C, et al. CDKN2A/p16 inactivation is related to pituitary adenoma type and size [J]. J Pathol, 2001, 193(4): 491 -497.
  • 9刘卫平,章翔,松本義人,国監勝三,岡田真樹,長尾省吾.MMP-2及MMP-9表达在侵袭性垂体腺瘤中的生物学意义[J].中华神经外科疾病研究杂志,2004,3(1):47-51. 被引量：5
  • 10王琪.垂体腺瘤的诊断和治疗进展[J].国外医学（耳鼻咽喉科学分册）,2005,29(1):57-60. 被引量：8

二级参考文献36

  • 1张纪,魏少波,许百男,周定标,程东源,段国升.714例垂体腺瘤的显微外科治疗及长期随访[J].中华神经外科杂志,1995,11(5):251-254. 被引量：75
  • 2Daughaday WH. Pituitary gigantism [J]. Endocrinol Metab Clin North Am, 1992, 21(3): 633-647.
  • 3Eugster EA, Pescovitz OH. Gigantism [J]. J Clin Endocrinol Metab, 1999, 84(12): 4379-4384.
  • 4Eastman RC, Gorden P, Glatstein E, et al. Radiation therapy of acromegaly [J]. Endocrinol Metab Clin North Am, 1992, 21(3): 693-712.
  • 5Morange I, De Boisvilliers F, Chanson P, et al. Slow release lanreotide treatment in acromegalic patients previously normalized by octreotide [J]. J Clin Endocrinol Metab, 1994, 79(1): 145-151.
  • 6Lu PW, Silink M, Johnston I, et al. Pituitary gigantism [J]. Arch Dis Child, 1992, 67(8): 1039-1041.
  • 7Cappabianca P, Cavallo LM, Mariniello G, et al. Easy sellar reconstruction in endoscopic endonasal transsphenoidal surgery with polyester-silicone dural substitute and fibrin glue: technical note [J]. Neurosurgery, 2001, 49(2): 473-476.
  • 8El-Banhawy OA, Halaka AN, EL-Dien AE, et al. Sellar floor reconstruction with nasal turbinate tissue after endoscopic endonasal transsphenoidal surgery for pituitary adenomas [J]. Minim Invasive Neurosurg, 2003, 46(5): 289-292.
  • 9Zada G, Kelly DF, Cohan P, et al. Endonasal transsphenoidal approach for pituitary adenomas and other sellar lesions: an assessment of efficacy, safety, and patient impressions [J]. J Neurosurg, 2003, 98(2): 350-358.
  • 10de Divitiis E, Cappabianca P, Cavallo LM. Endoscopic transsphenoidal approach: adaptability of the procedure to different sellar lesions [J]. Neurosurgery, 2002, 51(3): 699-705.

共引文献65

同被引文献113

  • 1汪晓英,俞建波,童鹰.女性垂体腺瘤的临床特征及诊治[J].浙江医学,2004,26(10):767-769. 被引量：4
  • 2方卫华.多发性内分泌腺瘤的诊治体会[J].安徽医学,2005,26(1):45-46. 被引量：1
  • 3泰尚振,马廉亭,朱贤立,徐国政,龚杰,杨铭,余泽,姚国杰,胡军民,潘力,张新元,李俊,贺道华.102例显微神经外科手术体会[J].中国临床神经外科杂志,1999,4(3):17-18. 被引量：7
  • 4巩丽,李艳红,张伟,赵建业,朱少君,李爱宁,苏勤.鼻腔血管球瘤临床病理观察[J].诊断病理学杂志,2005,12(5):368-369. 被引量：1
  • 5王征.经鼻蝶入路垂体瘤切除术的护理[J].临床医药实践,2006,15(1):61-62. 被引量：29
  • 6Weidner N,Semple JP,Welch WR,et al.Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma[J].New Engl J Med,1991,324(1):1-8.
  • 7Altieri DC.Survivin,versatile modulation of cell division and apoptosis in cancer[J].Oncogene,2003,22(53):8581 -8589.
  • 8Blanc-Brude OP,Yu J,Simosa H,et al.Inhibitor of apoptosis protein Survivin regulates vascular injury[J].Nat MOd,2002,8(9):987-994.
  • 9OConnor DS,Schechner JS,Adida C,et al.Control of apoptosis during angiogenesis by Survivin express in endothelial cells[J].Am J Pathol,2000,156(2):393 -398.
  • 10Chang SY,Huang H,Nagane M,et al.Suppression of g]ioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor[J].Proc Natl Acad Sci USA,1996,93(3):8502-8507.

引证文献13

二级引证文献43

中华神经外科疾病研究杂志
2005年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部